Figure 1. Atg7 deletion diminishes the cellularity of bone marrow CD11b+ myeloid cells. (A–D) Graphical and statistical analysis of CD11b and Ly6G by flow cytometry in the bone marrow cells of wild-type and Atg7 or Atg5 hematopoietic-specific deleted mice. (A, C) Number of CD11b+Ly6G- and CD11b+Ly6G+ myeloid cells in the bone marrow of wild-type and Atg7 or Atg5-deleted mice. (B, D) Percentage of CD11b+Ly6G- and CD11b+Ly6G+ myeloid cells in the bone marrow of wild-type and Atg7 or Atg5-deleted mice. (E, F) Percentage of CD11b+ and CD11b- myeloid cells in the bone marrow of wild-type and Atg7 or Atg5-deleted mice. (G, H) Percentage of Ly6G+ and Ly6G- myeloid cells in CD11b+ myeloid cells from the bone marrow of wild-type and Atg7 or Atg5-deleted mice.